“…Lipid-based nanocarriers are among the most promising systems for this purpose because of their high biocompatibility, ability to overcome the BBB, improved encapsulation capacity, and the possibility to modify their surface to improve tumor targeting; , moreover, these systems can be designed to release their cargo when exposed to a specific stimulus (e.g., pH, enzymes, temperature). As a consequence, various multimodal approaches to antitumor drug delivery have been explored, combining conventional therapeutic strategies ( e.g., chemotherapy) with other emerging alternatives such as magnetic hyperthermia (MH), photothermal therapy (PTT), and gene therapy. − Among them, MH is a promising strategy to develop a minimally invasive, localized, and remote antitumor treatment. − Conversely to conventional pharmacological agents used for cancer treatment or other methods of whole-body or regional hyperthermia, the heating in MH remains highly localized, and it depends on the simultaneous presence of magnetic nanoparticles and their excitation under an external alternating magnetic field (AMF) . This contributes to minimize systemic side effects and allows for a better recovery of the neighboring healthy cells or tissues, since the microenvironment of the treated area is not strongly stressed. , …”